image-media-type
media-bottom
true
pd-y-32
Injection Needles
5
neutrals-100
Nanopass™ 34G Needles are the world’s thinnest double-tapered 34G pen needles1, featuring a 22% thinner asymmetric bevel needle aiming at a better flow2 than comparable 32G designs.
neutrals-100
pd-y-64
true
tab1
Description
Product-images
Product Images
Characteristics
Characteristics
General-Specifications
Specifications
Downloads
Downloads
Related-Products
Related Products
References-Disclaimer
References
pd-y-32
Product Images

Nanopass™ 34G Needles

grid-texts-70
media-top
true
pd-y-32
pd-y-64
Characteristics

Nanopass™ 34G Needles

Engineered to support patient comfort during regular injections for diabetes and other chronic conditions, the Nanopass™ 34G Needle features a 22% thinner double-tapered needle with better flow2 than comparable 32G designs. Configured to fit most common pen injectors3 , Terumo’s pen needles with an asymmetric bevel address the penetration resistance, leading to a smoother insertion4 - which is expected to be a major influencing factor for patient’s wellbeing and adherence to long-to-lifetime-lasting (self-)injections. Designed for the subcutaneous (SC) injection of therapeutics, including insulin and human growth hormones (HGH), Nanopass™ 34G Needles offer the quality and supply reliability needed to meet drug developers’ toughest parenteral delivery challenges and product commercialization goals.
grid-texts-70
media-top
true
Nanopass™ 34G Needles designed with patient comfort in mind
  • The asymmetric bevel needle tip aims to reduce pain during needle insertion as the special shape is expected to cut the skin rather than piercing it. This special needle tip shape contributes to patient comfort5.
  • 34G needles are 22% thinner than 32G needles, which reduces the probability of touching pain receptors in the skin.
  • Optimized flow for less injection force than 32G needles as demonstrated with insulin2
normal
Pen Injector Needles engineered for automated environments
  • Nanopass™ 34G Needles are individually packed and sealed in an ergonomic plastic case for automated assembly and easier patient handling
reverse
Nanopass™ 34G Needle Regulatory Status & Quality Details
  • Radiation sterilization to a Sterility Assurance Level of at least 10-6
  • In compliance with applicable ISO standards and Pharmacopoeia
  • CE certified: CE 0197
  • Certifying (Notified) Body: TÜV Rheinland LGA Products GmbH, Germany
  • Proven track record of delivering quality and reliability as a globally operating company
normal
pd-y-64
General Specifications

Specifications for Nanopass™ 34G Needles

Nanopass™ 34G Needles are intended for use with a pen injector for subcutaneous (SC) injections of drugs, such as insulin or human growth hormone (HGH).
grid-texts-70
media-top
true

The device has no components made of natural rubber latex. For a detailed list of compatible devices, see the Nanopass™ Needle box.
neutrals-100
Item Specifications
4
neutrals-100
pd-y-64
pd-y-64

Global Solutions for Pen Injector Needles

Nanopass™ 34G Needles are available to drug product manufacturers globally. For more information about product availability, specifications, and applicable standards, download our data sheet.

Please note that Nanopass™ 34G is not available in USA and Canada

Please note that some products may not be available in all regions, reach out to your local Terumo Pharmaceutical Solutions Pharmaceutical Contact for details. All brand names are trademarks or registered trademarks owned by TERUMO CORPORATION, its affiliates, or unrelated third parties.

Contact Us
Contact Us
/content/psd-ia/en/contact
button psd-primary
text-vertical-center
image-media-type
media-right
true
pd-y-64
Downloads

Nanopass™ 34G Needles Information

media-top
true
pd-y-64

References

1. Based on research by Terumo Corporation in November 2020

2. Study NP34_basic technical comparison Asakura T., 2013, Jpn J Med Pharm Sci 69(1) 147-155

3. For a detailed list of compatible devices see Nanopass ™ Needle box.

4. Diabetol Int (2016) 7:259–265

5. Pen needle design influences ease of insertion, pain and skin trauma in subjects with type 2 diabetes Kezia A Praestmark, 1, E, Morten L Jenzen, 3 Nils B Madsen, 2 JOnas Kildegaard, 4 Bente M Stallknecht

neutrals-100
pd-y-64
pd-y-32
Related Products
2
neutrals-100
pd-y-32
View All Injection Needles
View All Injection Needles
/content/psd-ia/en/products/injection-needles
psdPrimary
pd-y-64

Didn't find what you were looking for?

neutrals-100
View our products in our Product Index
View our products in our Product Index
/content/psd-ia/en/products
psdPrimary
pd-y-64
pd-y-64

This product is also available for healthcare professionals.

We’re here to connect you with the right team.
Nanopass™ 34G Needles are also part of the Terumo Life Care Solutions (LCS) portfolio.
Visit Terumo LCS
Visit Terumo LCS
https://www.terumo-europe.com/en/ medical-care-solutions/products/product-type/pen-needles/nanopass-needle-for-pen-injectors-32-5-g.html
button psd-primary
image-media-type
media-left
true
pd-y-64
pd-y-64
Contact

Connect with Our Experts for Tailored Support

We are here to help. For more information about our Nanopass™ 34G Needles product availability, specifications, and applicable standards, download our data sheet or contact your Terumo Pharmaceutical Solutions representative today.
Contact Us
Contact Us
/content/psd-ia/en/contact
button psd-primary
grid-texts-50
text-vertical-center
image-media-type
TBD
default-aspect-ratio
media-right
true
pd-y-64